Zobrazeno 1 - 8
of 8
pro vyhledávání: '"H M, Knol"'
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 166
About 200 pregnant women in the Netherlands are yearly diagnosed with cancer. Pregnant women with cancer are often diagnosed later than non-pregnant women because symptoms of cancer are common during pregnancy and may elude suspicion. We report a pat
Autor:
Johanna Kluin-Nelemans, Dick H. Bogchelman, Sophie Wiewel-Verschueren, Andre B. Mulder, van der Ate Zee, H. M. Knol, Karina Meijer, Ton Lisman
Publikováno v:
Journal of Thrombosis and Haemostasis, 12(9), 1488-1493. Wiley
BackgroundBleeding disorders have been recognized as important etiologic or contributory factors in women with heavy menstrual bleeding. Fibrinolysis in the endometrium plays a role in heavy menstrual bleeding. It is unknown whether increased systemi
Autor:
Maas Jan Heineman, H. M. Knol, M. J. Pelinck, N. E. A. Vogel, Arnold Simons, Eric Arts, Annemieke Hoek
Publikováno v:
Human Reproduction, 23(8), 1808-1814. Oxford University Press
Human reproduction (Oxford, England), 23(8), 1808-1814. Oxford University Press
Human reproduction (Oxford, England), 23(8), 1808-1814. Oxford University Press
BACKGROUND: In modified natural cycle IVF (MNC-IVF), treatment is aimed at using the one follicle that spontaneously develops to dominance, using a GnRH-antagonist together with gonadotrophins in the late follicular phase only. The MNC-IVF is of inte
Publikováno v:
Journal of Thrombosis and Haemostasis, 8(8), 1874-1876
Journal of Thrombosis and Haemostasis, 8(8), 1874-1876. Wiley
Journal of Thrombosis and Haemostasis, 8(8), 1874-1876. Wiley
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 17(2)
Reproductive choices, pregnancy and childbirth are influenced by culture and traditions. This probably also plays a role in carriers of haemophilia. The aim of the study is to evaluate the reproductive choices and obstetrical experiences in the curre
Publikováno v:
Journal of Thrombosis and Haemostasis, 7(5), 903-906. Wiley
Journal of thrombosis and haemostasis, 7(5), 903-906. Wiley-Blackwell
Journal of thrombosis and haemostasis, 7(5), 903-906. Wiley-Blackwell
Thrombin-activatable fibrinolysis inhibitor (TAFI) is a procarboxypeptidase that suppresses fibrinolysis by removing C-terminal lysine residues from partially degraded fibrin [1]. These residues are involved in binding of plasminogen and tissue-type
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66a4f4bc175332b6c6b73267f5b91a95
https://research.rug.nl/en/publications/c6513950-0fcc-4764-a1ca-dfb227c717d7
https://research.rug.nl/en/publications/c6513950-0fcc-4764-a1ca-dfb227c717d7
Autor:
Jan van der Meer, Karly Hamulyák, Saskia Middeldorp, Martin H. Prins, Nic J. G. M. Veeger, H. M. Knol, Harry R. Bueller
Publikováno v:
Blood, 112(11), 639-640. AMER SOC HEMATOLOGY
Trombin-activatable fibrinolysis inhibitor (TAFI) is a procarboxypeptidase which suppresses fibrinolysis by removing carboxy-terminal lysine residues from partially degraded fibrin. A recent study in pregnant mice suggested that fibrin degradation pr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.